Immupharma Share Discussion Threads

[luminoso] 08/1/2018 13:10

I would expect this to be updated, if there is any truth in it.

[nw99] 08/1/2018 13:10

I don't have a link just got it in email from my broker

[hottingup] 08/1/2018 13:09

I presume some territories finished the Phase 3 trial some time ago and all the data from them has already been collected by Simbac-Orion and could be unblinded the day after the last patient evaluation in the one outstanding territory next Wednesday.

Thus by the end of next week IMM could already have results for say the US and EU, and just be waiting for Mauritius, but would have a good idea of outcomes from the unblinded groups.

[luminoso] 08/1/2018 13:06

nw99

wheres the link to that ?

[hottingup] 08/1/2018 13:06

10/4/2013
20:26
Evening Standard-Market Round up....



PORTFOLIO BUY IMMUPHARMA

Snap up ImmuPharma, Panmure Gordon urges. It's fallen sharply and the broker feels the market "is overlooking the potential" of the drugs and development business. Shares are about 38p a pop and Panmure gives a target price of 150p. It adds that "ultimately ImmuPharma shares are worth significantly more than the current share price".

angeln1
Read Full Thread
Reply
10/4/2013
20:17

[herschel k] 08/1/2018 13:05

nw998 Jan '18 - 13:04 - 8980 of 8981
0 0 0
MAIN MARKET AND AIM
----------
BERNSTEIN RAISES RYANAIR TO 'MARKET-PERFORM' (UNDERPERFORM) - PRICE TARGET 15 EUR
----------
CANACCORD RAISES MATTIOLI WOODS TO 'BUY' ('HOLD') - TARGET 840 PENCE
----------
PANMURE CUTS IMMUPHARMA TO 'SELL' ('BUY') - TARGET 100 PENCE


----------------------------------------------------------------------------

anyone can write the above.

proof please - just provide the link to the article - really EASY to do it.

[waterloo01] 08/1/2018 13:05

From the last Finncap note in December

Valuation – risk adj. DCF indicates £307m pre-readout value increasing 87%
to £573m (443p per share) on +ve trial results (excludes upfront/milestone
payments which could equal £500m). We initiate with Buy and TP of 237p.

[nw99] 08/1/2018 13:04

Yes a holder thanks to SCSW but I have a troll in John09

[nw99] 08/1/2018 13:04

MAIN MARKET AND AIM----------BERNSTEIN RAISES RYANAIR TO 'MARKET-PERFORM' (UNDERPERFORM) - PRICE TARGET 15 EUR ----------CANACCORD RAISES MATTIOLI WOODS TO 'BUY' ('HOLD') - TARGET 840 PENCE----------PANMURE CUTS IMMUPHARMA TO 'SELL' ('BUY') - TARGET 100 PENCE

[waterloo01] 08/1/2018 13:01

As far as I'm aware they have not updated since this was a buy at 50p (with a 100p target). Last note of substance was Finncap and that had some serious upside.

[john09] 08/1/2018 12:59

Yes and NW99 misleads 100 percent for his on personal gain he’s never posted here before and now all of a sudden he’s a holder but he’s helpfully also springing up with bad news . Panmure wouldn’t rate this a sell given the trials it’s lunacy

[divinessence] 08/1/2018 12:57

IMM is one of SCSW's NAPS for 2018. They do their homework quite thoroughly so all this Panmure alleged stuff is BS imho. Plenty of buys going on and much more to come I believe.

[bermudashorts] 08/1/2018 12:42

WH - are you on twitter?

[wantonhearts] 08/1/2018 12:40

There's too many clowns here nowadays. I don't even bother logging on anymore for weeks at a time.

Anyone fancy setting up a private forum for the old guard for sensible discussion like the good old days?

[che7win] 08/1/2018 12:30

By the way, I'm not sure what the expectations are for success of these trials, the 60% was only for illustration.Management seem to be quite confident though, and preparing documentation on expectations of a successful outcome.

[nw99] 08/1/2018 12:30

I am long the stock why would I lie ? think about it John you have a problem

[nw99] 08/1/2018 12:29

PANMURE CUTS IMMUPHARMA TO 'SELL' ('BUY') - TARGET 100 PENCE I don't lie John 09

[che7win] 08/1/2018 12:24

John, How can you say anything is frothy?If the company Lupus drug has 60% chance of success and multi-billion potential, on Lupus alone we should on risk basis be valued at 60% of say $1.5 billion revenue until we hear results.Panmure I don't know about, but they seem to have not moved their price target since last April and just adjusted their outlook based in current share price?I prefer Finncaps 237p target pre results, seems about right, 897p if success.

[john09] 08/1/2018 12:10

Still too frothy . Not sure about Panmure cutting rating though ignore NW99 he lies frankly

[nw99] 08/1/2018 12:10

Heard from my broker no confirmation